Home

Perioada operatorie marionetă Separare easl guideline nafld biomarkers table Embrion Rundă Empiric

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of  liver disease severity and prognosis – 2021 update - Journal of Hepatology
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update - Journal of Hepatology

Comparison of NAFLD Management Guidelines in Adults From the United... |  Download Scientific Diagram
Comparison of NAFLD Management Guidelines in Adults From the United... | Download Scientific Diagram

Algorithm for nonalcoholic fatty liver disease (NAFLD) evaluation.... |  Download Scientific Diagram
Algorithm for nonalcoholic fatty liver disease (NAFLD) evaluation.... | Download Scientific Diagram

Recent advances in non-invasive diagnosis and medical management of  non-alcoholic fatty liver disease in adult | Egyptian Liver Journal | Full  Text
Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult | Egyptian Liver Journal | Full Text

American Association of Clinical Endocrinology Clinical Practice Guideline  for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in  Primary Care and Endocrinology Clinical Settings - Endocrine Practice
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice

Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty  Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive  Approaches
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

Advancing the global public health agenda for NAFLD: a consensus statement  | Nature Reviews Gastroenterology & Hepatology
Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology

JCM | Free Full-Text | Nonalcoholic Steatohepatitis: A 9-Year Follow Up  Cohort Study
JCM | Free Full-Text | Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study

Frontiers | Controversies and Opportunities in the Use of Inflammatory  Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease

EASL–EASD–EASO Clinical Practice Guidelines for the management of  non-alcoholic fatty liver disease
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components  in Its Development
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development

Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery,  Based on Guideline Updates: A Mini Review | Journal of Health Reports and  Technology | Full Text
Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review | Journal of Health Reports and Technology | Full Text

EASL–EASD–EASO Clinical Practice Guidelines for the management of  non-alcoholic fatty liver disease | SpringerLink
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | SpringerLink

Frontiers | Application of Fatty Liver Inhibition of Progression Algorithm  and Steatosis, Activity, and Fibrosis Score to Assess the Impact of  Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
Frontiers | Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

Frontiers | Analysis of Common Pathways and Markers From Non-Alcoholic Fatty  Liver Disease to Immune-Mediated Diseases
Frontiers | Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

The diagnostic conundrum in non-alcoholic fatty liver disease
The diagnostic conundrum in non-alcoholic fatty liver disease

Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the  Study of the Liver and British Society of Gastroenterology NAFLD Special  Interest Group -
Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group -

Metabolic signatures across the full spectrum of non-alcoholic fatty liver  disease - JHEP Reports
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease - JHEP Reports

Non-Alcoholic Fatty Liver Disease (NAFLD) — EACS Guidelines
Non-Alcoholic Fatty Liver Disease (NAFLD) — EACS Guidelines

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and  nonalcoholic steatohepatitis: From clinical proteomics to microbiome
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome

EASL clinical practice guidelines for the management of occupational liver  diseases - Colombo - 2020 - Liver International - Wiley Online Library
EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library

Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty  Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Pharmacological Therapeutics: Current Trends for Metabolic  Dysfunction-Associated Fatty Liver Disease (MAFLD)
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Current NAFLD guidelines for risk stratification in diabetic patients have  poor diagnostic discrimination | Scientific Reports
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports